fluticasone-propionate--salmeterol-xinafoate-drug-combination and Substance-Withdrawal-Syndrome

fluticasone-propionate--salmeterol-xinafoate-drug-combination has been researched along with Substance-Withdrawal-Syndrome* in 1 studies

Trials

1 trial(s) available for fluticasone-propionate--salmeterol-xinafoate-drug-combination and Substance-Withdrawal-Syndrome

ArticleYear
Seretide withdrawal increases airway inflammation in moderate COPD patients.
    European journal of clinical pharmacology, 2009, Volume: 65, Issue:11

    Topics: Aged; Airway Obstruction; Albuterol; Androstadienes; Drug Combinations; Fluticasone-Salmeterol Drug Combination; Forced Expiratory Volume; Humans; Inflammation; Pulmonary Disease, Chronic Obstructive; Substance Withdrawal Syndrome

2009